Pipeline
Currently, we are pursuing the development of therapeutic agents from medicinal mushrooms against aggressive breast cancers such as triple negative and inflammatory breast cancer. Dynamiko Pharmaceutics is determined to develop effective, selective, and affordable therapeutics based on natural products.